InflammaSense 获得 3800 万美元的 ARPA-H CIRCLE 奖金，以推进重症监护中的实时免疫监测
InflammaSense，一家医疗科技公司，已获得ARPA-H高达3800万美元的资助，用于利用其VITALx-patch可穿戴传感器和ARC cascade-endotyping分类器监测危重患者中的自主神经和炎症标志物。
为什么重要. 这项技术有可能改善对如败血症等严重疾病的认识和治疗，从而挽救生命并降低医疗成本。
01
影响到谁
- 1InflammaSense
- 使用 →事实
- 属于 →事实
- 位于 →事实
02
证据
- PPR Newswire news releases公司披露2026-10-07 18:00
InflammaSense is a pre-revenue medtech company based in La Jolla, California, developing autonomic neurography (ANG) technology for real-time immune monitoring.
- PPR Newswire news releases公司披露2026-10-07 18:00
InflammaSense joins the program as a subaward performer under prime awardee the University of Vermont, working alongside UVM's Gary An on the ReSCUED effort within CIRCLE.
- PPR Newswire news releases公司披露2026-10-07 18:00
InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology
- PPR Newswire news releases公司披露2026-10-07 18:00
InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology, today announced its selection as a performer on an Advanced Research Projects Agency for Health (ARPA-H) CIRCLE program receiving up to $38M to transform how clinicians…
- PPR Newswire news releases公司披露2026-10-07 18:00
Under the subaward, InflammaSense will deploy its VITALx-patch, a non-invasive wearable sensor, to measure autonomic and inflammatory signatures in up to 200 severely critically ill patients across three clinical sites. Data will feed the company's Autonomic Research Core (ARC)…
- PPR Newswire news releases公司披露2026-10-07 18:00
LA JOLLA, Calif., Oct. 7, 2026 /PRNewswire/ -- InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology, today announced its selection as a performer on an Advanced Research Projects Agency for Health (ARPA-H) CIRCLE program r…